MDX-010

A drug used with nivolumab to treat a certain type of colorectal cancer that has mutations (changes) in genes involved in DNA repair. It is also used with nivolumab in some patients to treat advanced renal cell carcinoma that has not already been treated. MDX-010 is also used alone to treat melanoma that cannot be removed by surgery or has spread to other parts of the body. It is also used as adjuvant therapy to treat melanoma in the skin and lymph nodes in patients who have already had surgery. It is also being studied in the treatment of other types of cancer. MDX-010 binds to a substance called CTLA-4, which is found on T cells (a type of white blood cell). MDX-010 may block CTLA-4 and help the immune system kill cancer cells. It is a type of monoclonal antibody and a type of immune checkpoint inhibitor. Also called ipilimumab and Yervoy.

• Dailymed label info on MDX-010
• FDA MDX-010

MDX-010 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski